Travatan and Common peroneal nerve dysfunction - a phase IV clinical study of FDA data

Summary:

Common peroneal nerve dysfunction is reported as a side effect among people who take Travatan (travoprost), especially for people who are female, 60+ old, also take Januvia, and have Acute myeloid leukaemia.

The phase IV clinical study analyzes which people have Common peroneal nerve dysfunction when taking Travatan. It is created by eHealthMe based on reports of 12,807 people who have side effects when taking Travatan from the FDA, and is updated regularly.

What is Travatan?

Travatan has active ingredients of travoprost. It is often used in glaucoma. eHealthMe is studying from 13,103 Travatan users. Check the latest studies of Travatan.

What is Common peroneal nerve dysfunction?

Common peroneal nerve dysfunction (dysfunction of nerve controlling movement and sensation to the lower leg, foot and toes) is found to be associated with 651 drugs and 1,131 conditions by eHealthMe. Check the latest studies of Common peroneal nerve dysfunction.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 22, 2026

12,807 people reported to have side effects when taking Travatan.
Among them, 12 people (0.09%) have Common peroneal nerve dysfunction.

Could Travatan cause Common peroneal nerve dysfunction?

Among these 12 people:

What is the gender of people who have Common peroneal nerve dysfunction when taking Travatan? *

female: 66.67 %
male: 33.33 %

What is the age of people who have Common peroneal nerve dysfunction when taking Travatan? *

What are other drugs people take besides Travatan? *

What are other side effects people have besides Common peroneal nerve dysfunction? *

Weakness: 6 people, 50.00%
Gait Disturbance: 5 people, 41.67%
Decreased Immune Responsiveness: 5 people, 41.67%
Hypokinesia (decreased bodily movement): 5 people, 41.67%
Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 5 people, 41.67%
Herpes Zoster: 5 people, 41.67%
Memory Loss: 5 people, 41.67%
Mobility Decreased (ability to move is reduced): 5 people, 41.67%
Diarrhea: 4 people, 33.33%
Neuropathy Peripheral (surface nerve damage): 4 people, 33.33%

What are the existing conditions these people have? *

Stress And Anxiety: 3 people, 25.00%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 3 people, 25.00%
Pain: 3 people, 25.00%
Nausea (feeling of having an urge to vomit): 3 people, 25.00%
Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 3 people, 25.00%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 25.00%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 3 people, 25.00%
Breast Cancer Metastatic: 2 people, 16.67%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 8.33%
Diarrhea: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Travatan and have Common peroneal nerve dysfunction?

- Check whether Common peroneal nerve dysfunction is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Travatan:

Travatan (13,103 reports)

Browse all side effects of Travatan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Common peroneal nerve dysfunction:

Common peroneal nerve dysfunction (651 drugs)

Browse all the conditions that are associated with Common peroneal nerve dysfunction:

Common peroneal nerve dysfunction (1,131 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on travoprost (the active ingredients of Travatan) and Travatan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.